+91 9650760803 
Published: April 17, 2020 | Updated: July 20, 2026
Key Takeaways
- 01. Therapy addresses limb ischemia:
Stem cell interventions aim to treat severe limb ischemia caused by Buerger’s disease by promoting new blood vessel growth and improving circulation. - 02. Early evidence shows ulcer healing and walking improvement:
In a small study of 18 participants, bone-marrow-derived stem-cell treatment reduced ulcer area from about 5.04 cm² to 1.48 cm² and increased pain-free walking distance from around 38 m to 284 m. - 03. Quality of evidence remains very low:
The systematic review identified only one randomized trial with a high risk of bias and very small sample size. Findings are preliminary and not definitive. - 04. Tobacco cessation and standard care remain essential:
Since Buerger’s disease is triggered by tobacco use and vascular inflammation, quitting smoking and maintaining standard vascular care are still the foundation of management.
Overview
Buerger’s disease, medically known as Thromboangiitis Obliterans, is a rare and serious vascular condition in which small and medium-sized arteries and veins — most commonly in the hands and feet — become inflamed and blocked by clots. Unlike the more common atherosclerotic vascular diseases, Buerger’s disease is not caused by plaque buildup. Instead, it involves an inflammatory process that progressively narrows the blood vessels, cutting off circulation to the extremities.
Left unmanaged, this restricted blood flow can lead to severe pain, non-healing ulcers, tissue death (gangrene), and in advanced cases, amputation of the affected limb. The disease is strongly and almost exclusively associated with tobacco use, and it typically affects men and women between the ages of 20 and 40 who smoke or use other tobacco products.
Because Buerger’s disease shares underlying vascular and ischemic mechanisms with related conditions, patients exploring treatment options often also review information on Critical Limb Ischemia (CLI) and Cardiovascular Disease, both of which involve compromised blood flow and are being studied through similar regenerative approaches.
What Is Buerger’s Disease?
Buerger’s disease causes inflammation and clot formation within small and medium arteries and veins, most often in the legs, though it can also affect the arms. Its exact cause remains unclear, but the near-universal link to smoking makes tobacco cessation the single most important factor in disease management. Continued tobacco use is associated with faster disease progression and a substantially higher risk of amputation.
Prevention and Long-Term Management
There is currently no cure for Buerger’s disease, but the progression of the disease can often be slowed — and symptoms improved — through consistent lifestyle changes:
- Complete tobacco cessation — the single most effective step a patient can take, as continued use is strongly linked to disease progression and limb loss.
- Avoiding cold exposure, which can trigger vasospasm and worsen circulation to already compromised tissue.
- Wearing warm clothing and protective footwear in cold conditions.
- Regular physical activity to support peripheral circulation.
- A balanced, vascular-friendly diet.
Prognosis
When diagnosed early and managed properly — particularly with complete tobacco cessation — most patients with Buerger’s disease can expect a normal life expectancy, though ongoing vascular monitoring remains important. When the disease continues to progress, particularly in patients who continue using tobacco, complications such as chronic ulcers or amputation become significantly more likely. This is why early diagnosis (see Diagnosis) and a comprehensive treatment plan (see Treatment) are so important.
Causes
Buerger’s disease is classified as a form of vasculitis — inflammation of the blood vessels — and its exact cause is not fully understood. However, decades of clinical observation point to several consistent contributing factors:
- Tobacco use — the overwhelming majority of patients diagnosed with Buerger’s disease are current or former heavy smokers, or users of other tobacco products such as chewing tobacco. Tobacco is believed to damage the inner lining of blood vessels, triggering inflammation, clot formation, and reduced blood flow to the extremities.
- Genetic susceptibility — the disease is more common in men than women and typically develops between the ages of 20 and 40. Individuals of Ashkenazi Jewish descent appear to carry an increased risk, suggesting a genetic predisposition layered on top of tobacco exposure.
- Immune system involvement — some researchers believe an abnormal immune or autoimmune response to components in tobacco may contribute to the vascular inflammation seen in the disease.
- Vascular damage and reduced blood flow — smoking both damages vessel walls directly and reduces circulation to the extremities, compounding the inflammatory injury over time.
If left untreated, this ongoing inflammatory and clotting process can progress to complete vessel blockage, tissue damage, and — in severe, advanced cases — the need for amputation of the affected limb. Understanding these causes is central to why tobacco cessation remains foundational to every treatment approach, including regenerative options discussed in the Treatment and Mechanism sections below.
Symptoms
The symptoms of Buerger’s disease vary from patient to patient but commonly progress through recognizable stages as circulation becomes increasingly compromised:
- Pain in the extremities — often one of the earliest signs, typically worse at night or with limb use, and may start as intermittent discomfort before becoming constant.
- Raynaud’s phenomenon — fingers or toes turning pale, cold, numb, or tingling in response to cold temperatures or stress, due to restricted blood flow.
- Ulcers — painful sores on the fingers or toes that heal slowly, if at all, due to poor circulation.
- Swelling — fluid buildup in the hands or feet caused by impaired circulation.
- Discoloration — skin on the extremities may appear pale, bluish, or purplish as oxygen-rich blood fails to reach the area.
- Gangrene — in advanced, untreated cases, prolonged lack of blood flow can cause tissue death, often necessitating amputation of the affected limb.
These symptoms tend to overlap with those seen in other vascular conditions such as Critical Limb Ischemia, which is why a thorough vascular evaluation (see Diagnosis) is essential to confirm the specific underlying condition before beginning any treatment plan.
Diagnosis
Because early diagnosis significantly improves long-term outcomes, patients experiencing symptoms of Buerger’s disease should seek medical evaluation promptly. Diagnosis typically follows a structured process:
Clinical History and Physical Examination
A physician will review the patient’s tobacco use history, symptom pattern, and family history, followed by a physical exam checking for signs of impaired circulation, discoloration, ulceration, or swelling in the hands and feet.
Confirmatory Tests
- Artery biopsy — a small tissue sample from an affected artery is examined for characteristic inflammatory changes.
- Doppler ultrasound — uses sound waves to detect blockages and assess blood flow in the affected arteries.
- MRI or CT scan — imaging techniques that reveal structural changes within the blood vessels caused by the disease.
- Angiogram — a contrast dye study that maps blood flow through the arteries and identifies areas of blockage.
Once the diagnosis is confirmed, the medical team works with the patient to build an individualized treatment plan, which may include lifestyle modification, medication, surgical options, and — for eligible patients — evaluation for regenerative approaches such as those described in the Treatment section below.
Treatment
Buerger’s disease damages small and medium blood vessels in the extremities, and if untreated, can progress to tissue damage and amputation. India has become one of the leading destinations for patients exploring stem cell–based regenerative approaches as a complement to conventional vascular care, alongside tobacco cessation and standard medical management.
Types of Stem Cells Studied for Buerger’s Disease
- Autologous stem cells — extracted from the patient’s own bone marrow or blood and reintroduced into affected tissue. This approach carries no risk of immune rejection, making it the most widely used option.
- Allogeneic stem cells — sourced from a screened, matched donor. While generally considered safe, this option carries a small residual risk of immune reaction.
- Embryonic stem cells — sourced from embryos; while scientifically studied, this source is not used in Viezec’s treatment protocols (see our Treatment Disclaimer).
What to Expect
Buerger’s disease involves chronic vessel inflammation and clot formation that impairs circulation, leading to pain, swelling, and ulceration. While there is no cure, stem cell therapy is being studied as a way to potentially reduce inflammation and support the formation of new blood vessels (angiogenesis) in affected limbs. This remains an experimental, investigational approach, with limited long-term data, and it is generally not covered by standard health insurance.
Types of Stem Cells Used in India
Indian regenerative medicine centers work with three broad categories of stem cells:
- Embryonic stem cells — derived from early-stage embryos, capable of developing into virtually any cell type.
- Adult stem cells — sourced from the patient’s own tissue (commonly bone marrow), with more limited but clinically relevant differentiation capacity.
- Induced pluripotent stem cells (iPSCs) — adult cells reprogrammed in the lab to behave similarly to embryonic stem cells.
Success Considerations
Outcomes vary significantly depending on disease stage. In earlier-stage Buerger’s disease, stem cell therapy has shown more encouraging results in symptom reduction and slowing disease progression. In advanced disease with established tissue damage, the therapy is less likely to reverse existing injury but may still help manage pain and improve overall quality of life. Every treatment decision should be made in consultation with a vascular and regenerative medicine team familiar with the condition.
Learn more about our lab processing standards here
Implantation
Stem cells for Buerger’s disease can be delivered through several administration routes, selected based on the location and severity of vascular involvement:
- Intravenous administration — systemic delivery through the bloodstream.
- Intrathecal (lumbar puncture) — used in select neurologically-linked cases.
- Intramuscular injection — delivered directly into affected muscle tissue in the limb.
- Intra-arterial delivery — cells are introduced through an artery supplying the affected limb, targeting the site of vascular compromise directly.
- Subcutaneous injection — administered just beneath the skin.
- Liberation angioplasty — a vascular procedure sometimes combined with cell-based therapy to improve blood flow.
- Surgical administration — reserved for select complex vascular cases.
Intra-arterial and intramuscular delivery are the routes most frequently used for limb-based conditions like Buerger’s disease, since they allow more direct access to the ischemic tissue than systemic infusion alone.
Read more about delivery methods here
Frequently Asked Questions
What is stem cell treatment for Buerger’s disease?
Stem cell treatment for Buerger’s disease involves using regenerative cells to improve blood flow, promote tissue repair, and reduce pain and ulcer formation in affected limbs.
Who is eligible for stem cell therapy for Buerger’s disease?
Patients with critical limb ischemia, non-healing ulcers, or pain due to Buerger’s disease who are not responding to conventional treatments may be considered suitable candidates after thorough evaluation.
How is the therapy administered?
Stem cells are typically injected into the affected limbs or delivered via intravenous infusion to enhance vascular regeneration and improve blood circulation.
Is stem cell therapy safe for Buerger’s patients?
When performed in certified clinics by experienced specialists, stem cell therapy is generally safe. Mild side effects may include temporary swelling, bruising, or minor discomfort at the injection site.
How long does it take to notice improvements?
Patients may observe gradual improvement in pain relief, ulcer healing, and limb circulation over several weeks to a few months, depending on disease severity and individual response.
How many sessions of stem cell therapy are required?
The number of sessions depends on individual condition and treatment goals. Typically, 1–3 sessions are administered, with follow-ups to monitor progress and vascular improvement.
Can stem cell therapy replace surgery or medications?
Stem cell therapy is generally used as a complementary approach alongside medications, lifestyle changes, and surgical interventions, rather than as a complete replacement.
How can I schedule a consultation for stem cell therapy?
You can schedule a consultation by contacting our clinic via phone, email, or the appointment request form on our website. Our experts will evaluate your condition and design a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Buerger’s Disease?
The cost of stem cell therapy for Buerger’s disease varies depending on the severity of arterial blockage, patient’s overall condition, type of stem cells used, number of sessions required, and the reputation of the treatment facility. Since the disease affects blood vessels and tissues, treatment often involves advanced regenerative protocols, which can influence overall cost. The price also varies between countries due to differences in healthcare standards and treatment infrastructure. Below is a comparative overview of treatment costs across popular medical destinations.
Cost Comparison: Select Countries
The table below provides approximate cost ranges shared by international clinics and patient reports for a complete stem cell therapy program, including medical assessment, cell preparation, injections, and follow-up consultations.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $18,000 – $30,000 | ₹14,90,000 – ₹24,80,000 |
| United Kingdom 🇬🇧 | $14,000 – $24,000 | ₹11,60,000 – ₹19,80,000 |
| Germany 🇩🇪 | $16,000 – $26,000 | ₹13,20,000 – ₹21,50,000 |
| Singapore 🇸🇬 | $12,000 – $20,000 | ₹9,90,000 – ₹16,50,000 |
While treatments in Western countries are technologically advanced, they often come at significantly higher prices due to hospital overheads and medical labor costs. On the other hand, India provides comparable quality care and stem cell therapy outcomes at a much lower cost, making it one of the most sought-after destinations for regenerative treatment of Buerger’s disease.
Lower costs in India are driven by efficient medical systems, affordable operational setups, and favorable currency rates — without compromising treatment quality. Indian hospitals are equipped with modern stem cell labs, skilled vascular specialists, and globally standardized safety protocols to ensure effective results for patients suffering from Buerger’s disease.
Why Choose Viezec?
Viezec partners with top hospitals and certified stem cell experts offering advanced care for vascular and ischemic disorders. We emphasize transparency in pricing, ethical treatment methods, and a patient-centered approach throughout your recovery process.
Get a Personalized Cost Estimate
Every case of Buerger’s disease is unique. Contact our healthcare team to receive a personalized quotation and a customized treatment plan designed to match your medical condition.
Improvements
Patients who respond well to stem cell–based treatment for Buerger’s disease may notice gradual improvements in several areas, including reduced pain, improved circulation and skin color in the affected limb, better wound and ulcer healing, and increased pain-free walking distance. Combined with sustained tobacco cessation and healthy lifestyle habits, these changes contribute to an overall improved quality of life.
It’s important to note that improvements vary from patient to patient depending on disease stage, duration of tobacco use, and individual vascular health, and are not guaranteed. Stem cell treatment in India is offered through experienced hospital networks with qualified staff supporting patients throughout the recovery process.
Mechanism
Buerger’s disease is fundamentally driven by chronic vascular inflammation triggered by tobacco exposure, which damages the vessel lining and promotes clot formation. Stem cell–based therapy, particularly using mesenchymal and bone-marrow–derived cells, is being studied for several potential mechanisms of action:
- Angiogenesis — stimulating the growth of new, small blood vessels around blocked or damaged arteries to restore circulation to affected tissue.
- Anti-inflammatory signaling — helping to reduce the chronic inflammatory activity that drives vessel narrowing.
- Tissue repair support — aiding the healing of ulcerated or damaged skin and underlying tissue in the limbs.
Tobacco cessation remains central to any treatment mechanism, since continued smoking actively works against the vascular repair processes that stem cell therapy aims to support. In some patients, symptom improvement has also been associated with lifestyle factors such as improved hydration and avoiding cold exposure, alongside medical or regenerative treatment.
For more information, read here
Our Promise
At Viezec, we are committed to advancing regenerative medicine responsibly for patients with vascular conditions such as Buerger’s disease. Our approach includes:
- Working with highly experienced vascular and regenerative medicine professionals.
- Applying current, evidence-informed medical techniques focused on patient health and safety.
- Ensuring every patient has access to safe, transparent, and ethically administered treatment.
- Supporting international and domestic patients throughout the full treatment journey.
For more details, read here
Treatment Results
Research into bone-marrow–derived stem cell therapy for Buerger’s disease has shown encouraging, though still preliminary, results. In one small study of 18 participants, treatment was associated with a reduction in ulcer area from approximately 5.04 cm² to 1.48 cm², and an increase in pain-free walking distance from around 38 meters to 284 meters.
However, a systematic review of the available evidence found only one randomized controlled trial, which carried a high risk of bias and a very small sample size. Broader outcomes — such as amputation rates, amputation-free survival, and long-term adverse effects — have not yet been rigorously assessed across larger patient populations. This means current findings, while promising, remain preliminary rather than definitive, underscoring the importance of individualized evaluation before pursuing treatment.
For more results, watch video
Testimonials
Nikhil A. – Pune, India – February 2020 – ⭐⭐⭐⭐☆
“Buerger’s disease left me with severe leg pain. After Viezec’s stem cell therapy, my circulation improved, and walking became easier.”
Sophie H. – Edinburgh, Scotland – May 2020 – ⭐⭐⭐⭐⭐
“I had constant numbness in my fingers. Post-treatment at Viezec, blood flow improved, and the pain has reduced significantly.”
Karim M. – Casablanca, Morocco – December 2020 – ⭐⭐⭐⭐☆
“My smoking-related Buerger’s condition caused ulcers. After Viezec’s therapy, the wounds started healing, and discomfort eased.”
Lucia V. – Milan, Italy – March 2021 – ⭐⭐⭐⭐⭐
“I struggled with poor circulation for years. Thanks to Viezec, my pain reduced, and my mobility has improved.”
Stefan B. – Vienna, Austria – September 2021 – ⭐⭐⭐⭐☆
“Buerger’s disease made daily life painful. After stem cell therapy, my blood circulation stabilized, and flare-ups reduced.”
Helena F. – Lisbon, Portugal – February 2022 – ⭐⭐⭐⭐⭐
“My brother suffered from foot ulcers. Viezec’s stem cell therapy helped healing and gave him relief from chronic pain.”
Rashid O. – Muscat, Oman – July 2022 – ⭐⭐⭐⭐☆
“Pain and swelling in my legs were constant. After therapy at Viezec, circulation improved, and I feel much better.”
Claire D. – Paris, France – April 2023 – ⭐⭐⭐⭐⭐
“I had recurring infections due to Buerger’s. Stem cell therapy at Viezec reduced the symptoms, and my quality of life improved.”
Jacob L. – Sydney, Australia – November 2023 – ⭐⭐⭐⭐☆
“My feet were always cold and painful. After Viezec’s treatment, blood flow improved, and I can walk comfortably again.”
Aylin K. – Istanbul, Turkey – June 2025 – ⭐⭐⭐⭐⭐
“Buerger’s disease was progressing fast. Thanks to Viezec’s stem cell therapy, my circulation improved, and pain is much less now.”
Treatment Disclaimer
Before undergoing this procedure, patients should understand that stem cell therapy remains an experimental, investigational approach that may not produce the desired effect in every case. Depending on individual evaluation, treatment may be declined, or the recommended protocol adjusted based on the patient’s health condition.
Our priority at Viezec is to provide the safest, most current techniques available, aligned with globally recognized standards. As with any medical treatment, no outcome can be guaranteed — individual biology varies, and results differ from patient to patient even with a similar diagnosis. No embryonic or fetal stem cells are used in any of our treatment protocols.
Scientific References
The following peer-reviewed publications and clinical studies support current research on stem cell therapy for Buerger’s Disease (Thromboangiitis Obliterans).
Conclusion
Stem cell therapy for Buerger’s disease offers a promising alternative for patients seeking relief from chronic inflammation and impaired blood flow. By promoting new blood vessel formation and improving circulation, this regenerative approach targets the root cause rather than only managing symptoms. At Viezec, we uphold the highest standards of ethical medical practice, patient safety, and personalized care. Our team collaborates with leading specialists across India to deliver advanced, evidence-based stem cell treatments designed to enhance mobility, reduce pain, and restore vascular health. If you or a loved one is exploring effective options for Buerger’s disease, contact Viezec today to learn how our expertise and compassionate approach can help you regain a better quality of life.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
We Also Offer Treatments For
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
